
Wednesday, February 02, 2022 2:48:22 PM

Liked By
Spread the love. Be the first to like this post!
Recent BRTX News
- Annual Report (10-k) • Edgar (US Regulatory) • 03/27/2023 10:02:48 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/22/2023 08:50:27 PM
- BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100 • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- BioRestorative Therapies to Participate at the 35th Annual ROTH MKM Conference on March 12 -14, 2023 • GlobeNewswire Inc. • 03/07/2023 11:30:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/03/2023 09:12:46 PM
- BioRestorative Therapies Receives Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program • GlobeNewswire Inc. • 03/02/2023 12:30:00 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/15/2023 11:35:05 AM
- BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program • GlobeNewswire Inc. • 02/08/2023 02:00:00 PM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 02/07/2023 11:01:59 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/07/2023 09:44:37 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 02:33:52 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/24/2023 05:28:21 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/05/2023 09:53:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/07/2022 11:05:30 PM
- BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem Targeting Polycystic Ovary Syndrome as an Indication • InvestorsHub NewsWire • 12/06/2022 02:52:00 PM
- BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication • GlobeNewswire Inc. • 12/06/2022 12:00:00 PM
- BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 12/05/2022 12:00:00 PM
- BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022 • GlobeNewswire Inc. • 11/29/2022 04:20:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/21/2022 12:50:00 PM
- BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 • GlobeNewswire Inc. • 11/16/2022 01:56:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 01:42:46 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/09/2022 09:52:31 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/04/2022 08:29:45 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/04/2022 08:28:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/04/2022 08:19:45 PM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM